EUVIMEDEUVIMED entdecken
Crossref

In silico studies on nicotinamide analogs as competitive inhibitors of nicotinamidase in methicillin-resistant Staphylococcus aureus

Jaikee Kumar Singh, Jai Singh, Ishita Jha, Tarini Rajput, Saurabh Srivastava, Sandeep Kumar Srivastava

Molecular Diversity · 2025

DOI: 10.1007/s11030-024-11036-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Jaikee Kumar Singh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Structural Biology & Bioinformatics Laboratory, Department of Biosciences, Manipal University Jaipur, Jaipur-Ajmer Express Highway, Jaipur, Rajasthan…. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Enzyme Inhibitors, Nicotinamidase, Niacinamide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nicotinamidase/PncA is a member of the hydrolase enzyme family, catalyzing the de-amidation of nicotinamide (NM) to nicotinic acid (NA) via salvage pathway. Products are fed into Preiss-Handler pathway for NAD+ biosynthesis which is an important enzyme cofactor and crucial for redox balance in microorganisms. Pathogens like methicillin-resistant Staphylococcus aureus (MRSA) are NAD+ auxotroph and rely on their host environment for NAD+ precursors to synthesize NAD+. Mutations in nicotinamidase/PncA have been reported to be associated with resistance to pyrazinamide (PZA), a front-line anti-tubercular drug, underlying its importance as an important link in NAD+ biosynthesis network in pathogenic organisms such as MRSA. The conserved features of PncA and essentiality of salvage route in MRSA and the absence of this enzyme in humans and other eukaryotes are attractive options to explore therapeutics against this target. In this work, we have screened novel substrate analogs from the PubChem database using virtual screening approaches employing fingerprint tanimoto-based 2D similarity search against Staphylococcus aureus PncA (SaPncA). Identified compounds were further assessed using molecular dynamics simulations to investigate conformational stability and structural integrity. We propose two analogs, namely L28 and L33 with greater stability, favorable binding and strong binding free energies in MM-PBSA calculations. The strategy could provide an important clue in developing similar compound scaffolds as potent drug-like molecules against MRSA and other pathogenic species harboring this enzyme. Smaller scaffolds of these molecules could be attractive options for fragment-based derivatization for inhibitor discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusEnzyme InhibitorsNicotinamidaseNiacinamideAnti-Bacterial AgentsMolecular Dynamics SimulationMolecular Docking SimulationComputer Simulation

Stichwörter der Autor:innen

In silico drug designMRSANAD+NicotinamidaseSalvage pathway

Substanzen

Enzyme InhibitorsNicotinamidaseNiacinamideAnti-Bacterial Agents

Autor:innen und Institutionen

  • Structural Biology & Bioinformatics Laboratory, Department of Biosciences, Manipal University Jaipur, Jaipur-Ajmer Express Highway, Jaipur, Rajasthan, 303007, India.
  • Department of Chemistry, Manipal University Jaipur, Jaipur, Rajasthan, 303007, India.
  • Structural Biology & Bioinformatics Laboratory, Department of Biosciences, Manipal University Jaipur, Jaipur-Ajmer Express Highway, Jaipur, Rajasthan, 303007, India. sandeepkumar.srivastava@jaipur.manipal.edu.

Förderung

  • Department of Biotechnology, Ministry of Science and Technology, India

Zitieren

APA

Singh, J. K., Singh, J., Jha, I., Rajput, T., Srivastava, S., & Srivastava, S. K. (2025). In silico studies on nicotinamide analogs as competitive inhibitors of nicotinamidase in methicillin-resistant Staphylococcus aureus. Molecular Diversity. https://doi.org/10.1007/s11030-024-11036-y

Vancouver

Singh JK, Singh J, Jha I, Rajput T, Srivastava S, Srivastava SK. In silico studies on nicotinamide analogs as competitive inhibitors of nicotinamidase in methicillin-resistant Staphylococcus aureus. Molecular Diversity. 2025. doi:10.1007/s11030-024-11036-y

BibTeX
@article{Singh2025,
  author = {Singh, Jaikee Kumar and Singh, Jai and Jha, Ishita and Rajput, Tarini and Srivastava, Saurabh and Srivastava, Sandeep Kumar},
  title = {In silico studies on nicotinamide analogs as competitive inhibitors of nicotinamidase in methicillin-resistant Staphylococcus aureus},
  journal = {Molecular Diversity},
  year = {2025},
  doi = {10.1007/s11030-024-11036-y}
}
Kostenlos starten →